• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022

    11/17/22 10:13:36 AM ET
    $AAP
    $AGIO
    $ALE
    $ARDX
    Auto & Home Supply Stores
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AAP alert in real time by email

    Upgrades

    Wolfe Research upgraded the previous rating for Matson Inc (NYSE:MATX) from Underperform to Peer Perform. In the third quarter, Matson showed an EPS of $6.89, compared to $6.53 from the year-ago quarter. The stock has a 52-week-high of $125.34 and a 52-week-low of $60.35. At the end of the last trading period, Matson closed at $63.35.

    UBS upgraded the previous rating for XPeng Inc (NYSE:XPEV) from Neutral to Buy. XPeng earned $0.43 in the second quarter, compared to $0.21 in the year-ago quarter. At the moment, the stock has a 52-week-high of $51.50 and a 52-week-low of $6.18. XPeng closed at $8.03 at the end of the last trading period.

    Summit Insights Group upgraded the previous rating for NVIDIA Corp (NASDAQ:NVDA) from Hold to Buy. NVIDIA earned $0.58 in the third quarter, compared to $1.17 in the year-ago quarter. At the moment, the stock has a 52-week-high of $307.11 and a 52-week-low of $108.13. NVIDIA closed at $159.10 at the end of the last trading period.

    Goldman Sachs upgraded the previous rating for Agios Pharmaceuticals Inc (NASDAQ:AGIO) from Sell to Neutral. For the third quarter, Agios Pharmaceuticals had an EPS of $1.49, compared to year-ago quarter EPS of $1.56. The current stock performance of Agios Pharmaceuticals shows a 52-week-high of $35.12 and a 52-week-low of $16.75. Moreover, at the end of the last trading period, the closing price was at $27.13.

    According to Argus Research, the prior rating for Equity Residential (NYSE:EQR) was changed from Hold to Buy. In the third quarter, Equity Residential showed an EPS of $0.92, compared to $0.77 from the year-ago quarter. The stock has a 52-week-high of $94.32 and a 52-week-low of $59.32. At the end of the last trading period, Equity Residential closed at $61.55.

    B of A Securities upgraded the previous rating for Intercontinental Exchange Inc (NYSE:ICE) from Neutral to Buy. Intercontinental Exchange earned $1.31 in the third quarter, compared to $1.30 in the year-ago quarter. The current stock performance of Intercontinental Exchange shows a 52-week-high of $137.40 and a 52-week-low of $88.60. Moreover, at the end of the last trading period, the closing price was at $104.02.

    According to Piper Sandler, the prior rating for Target Corp (NYSE:TGT) was changed from Neutral to Overweight. Target earned $1.54 in the third quarter, compared to $3.03 in the year-ago quarter. At the moment, the stock has a 52-week-high of $254.87 and a 52-week-low of $137.16. Target closed at $155.47 at the end of the last trading period.

    Wolfe Research upgraded the previous rating for Pinnacle West Capital Corp (NYSE:PNW) from Underperform to Peer Perform. Pinnacle West Capital earned $2.88 in the third quarter, compared to $3.00 in the year-ago quarter. The stock has a 52-week-high of $80.51 and a 52-week-low of $59.03. At the end of the last trading period, Pinnacle West Capital closed at $73.30.

    For Ardelyx Inc (NASDAQ:ARDX), Piper Sandler upgraded the previous rating of Neutral to Overweight. In the third quarter, Ardelyx showed an EPS of $0.14, compared to $0.42 from the year-ago quarter. At the moment, the stock has a 52-week-high of $2.18 and a 52-week-low of $0.49. Ardelyx closed at $1.22 at the end of the last trading period.

    JP Morgan upgraded the previous rating for ALLETE Inc (NYSE:ALE) from Underweight to Neutral. For the third quarter, ALLETE had an EPS of $0.59, compared to year-ago quarter EPS of $0.53. The stock has a 52-week-high of $68.61 and a 52-week-low of $47.77. At the end of the last trading period, ALLETE closed at $64.03.

    See all analyst ratings upgrades.

    Downgrades

    Evercore ISI Group downgraded the previous rating for Dominion Energy Inc (NYSE:D) from Outperform to In-Line. Dominion Energy earned $1.11 in the third quarter, compared to $1.11 in the year-ago quarter. The stock has a 52-week-high of $88.78 and a 52-week-low of $57.95. At the end of the last trading period, Dominion Energy closed at $59.61.

    For On Holding AG (NYSE:ONON), William Blair downgraded the previous rating of Buy to Hold. On Holding earned $0.07 in the third quarter, compared to $0.07 in the year-ago quarter. The stock has a 52-week-high of $40.22 and a 52-week-low of $15.44. At the end of the last trading period, On Holding closed at $18.40.

    Monness, Crespi, Hardt downgraded the previous rating for Salesforce Inc (NYSE:CRM) from Buy to Neutral. In the second quarter, Salesforce showed an EPS of $1.19, compared to $1.48 from the year-ago quarter. The current stock performance of Salesforce shows a 52-week-high of $256.87 and a 52-week-low of $136.04. Moreover, at the end of the last trading period, the closing price was at $155.12.

    Wolfe Research downgraded the previous rating for PACCAR Inc (NASDAQ:PCAR) from Outperform to Peer Perform. For the third quarter, PACCAR had an EPS of $2.21, compared to year-ago quarter EPS of $1.08. At the moment, the stock has a 52-week-high of $104.58 and a 52-week-low of $77.00. PACCAR closed at $103.40 at the end of the last trading period.

    According to Wolfe Research, the prior rating for Hub Group Inc (NASDAQ:HUBG) was changed from Outperform to Peer Perform. In the third quarter, Hub Group showed an EPS of $2.61, compared to $1.28 from the year-ago quarter. At the moment, the stock has a 52-week-high of $89.61 and a 52-week-low of $60.81. Hub Group closed at $82.89 at the end of the last trading period.

    According to Wolfe Research, the prior rating for Saia Inc (NASDAQ:SAIA) was changed from Outperform to Peer Perform. Saia earned $3.67 in the third quarter, compared to $2.86 in the year-ago quarter. The stock has a 52-week-high of $342.99 and a 52-week-low of $168.03. At the end of the last trading period, Saia closed at $248.06.

    For Norfolk Southern Corp (NYSE:NSC), Wolfe Research downgraded the previous rating of Outperform to Peer Perform. For the third quarter, Norfolk Southern had an EPS of $3.80, compared to year-ago quarter EPS of $3.06. The current stock performance of Norfolk Southern shows a 52-week-high of $298.99 and a 52-week-low of $203.65. Moreover, at the end of the last trading period, the closing price was at $249.72.

    For The Descartes Systems Group Inc (NASDAQ:DSGX), Wolfe Research downgraded the previous rating of Outperform to Peer Perform. In the second quarter, Descartes Systems Gr showed an EPS of $0.27, compared to $0.27 from the year-ago quarter. The stock has a 52-week-high of $82.86 and a 52-week-low of $56.19. At the end of the last trading period, Descartes Systems Gr closed at $73.18.

    According to UBS, the prior rating for NIO Inc (NYSE:NIO) was changed from Buy to Neutral. NIO earned $0.30 in the third quarter, compared to $0.06 in the year-ago quarter. At the moment, the stock has a 52-week-high of $33.80 and a 52-week-low of $8.38. NIO closed at $10.53 at the end of the last trading period.

    Monness, Crespi, Hardt downgraded the previous rating for Workday Inc (NASDAQ:WDAY) from Buy to Neutral. Workday earned $0.83 in the second quarter, compared to $1.23 in the year-ago quarter. The stock has a 52-week-high of $272.50 and a 52-week-low of $128.72. At the end of the last trading period, Workday closed at $155.39.

    Wolfe Research downgraded the previous rating for Public Service Enterprise Group Inc (NYSE:PEG) from Outperform to Peer Perform. Public Service Enterprise earned $0.86 in the third quarter, compared to $0.98 in the year-ago quarter. The current stock performance of Public Service Enterprise shows a 52-week-high of $75.61 and a 52-week-low of $52.51. Moreover, at the end of the last trading period, the closing price was at $57.79.

    According to Northcoast Research, the prior rating for Sprouts Farmers Market Inc (NASDAQ:SFM) was changed from Buy to Neutral. Sprouts Farmers Market earned $0.61 in the third quarter, compared to $0.56 in the year-ago quarter. At the moment, the stock has a 52-week-high of $35.34 and a 52-week-low of $22.56. Sprouts Farmers Market closed at $33.84 at the end of the last trading period.

    According to UBS, the prior rating for LPL Financial Holdings Inc (NASDAQ:LPLA) was changed from Buy to Neutral. For the third quarter, LPL Finl Hldgs had an EPS of $3.13, compared to year-ago quarter EPS of $1.77. The stock has a 52-week-high of $271.56 and a 52-week-low of $140.65. At the end of the last trading period, LPL Finl Hldgs closed at $218.42.

    For Science Applications International Corp (NYSE:SAIC), Jefferies downgraded the previous rating of Buy to Hold. Science Applications Intl earned $1.75 in the second quarter, compared to $1.97 in the year-ago quarter. At the moment, the stock has a 52-week-high of $113.03 and a 52-week-low of $78.10. Science Applications Intl closed at $107.34 at the end of the last trading period.

    For Advance Auto Parts Inc (NYSE:AAP), Guggenheim downgraded the previous rating of Buy to Neutral. In the third quarter, Advance Auto Parts showed an EPS of $2.84, compared to $3.21 from the year-ago quarter. The current stock performance of Advance Auto Parts shows a 52-week-high of $244.55 and a 52-week-low of $150.35. Moreover, at the end of the last trading period, the closing price was at $156.24.

    For Advance Auto Parts Inc (NYSE:AAP), Citigroup downgraded the previous rating of Buy to Neutral. Advance Auto Parts earned $2.84 in the third quarter, compared to $3.21 in the year-ago quarter. The stock has a 52-week-high of $244.55 and a 52-week-low of $150.35. At the end of the last trading period, Advance Auto Parts closed at $156.24.

    According to Citigroup, the prior rating for Quest Diagnostics Inc (NYSE:DGX) was changed from Neutral to Sell. Quest Diagnostics earned $2.36 in the third quarter, compared to $3.96 in the year-ago quarter. The stock has a 52-week-high of $172.50 and a 52-week-low of $120.40. At the end of the last trading period, Quest Diagnostics closed at $149.27.

    According to Citigroup, the prior rating for IQVIA Holdings Inc (NYSE:IQV) was changed from Buy to Neutral. For the third quarter, IQVIA Hldgs had an EPS of $2.48, compared to year-ago quarter EPS of $2.17. The current stock performance of IQVIA Hldgs shows a 52-week-high of $282.52 and a 52-week-low of $165.75. Moreover, at the end of the last trading period, the closing price was at $224.02.

    Stifel downgraded the previous rating for Kinnate Biopharma Inc (NASDAQ:KNTE) from Buy to Hold. For the third quarter, Kinnate Biopharma had an EPS of $0.70, compared to year-ago quarter EPS of $0.57. The stock has a 52-week-high of $18.39 and a 52-week-low of $5.75. At the end of the last trading period, Kinnate Biopharma closed at $9.67.

    According to Deutsche Bank, the prior rating for Target Corp (NYSE:TGT) was changed from Buy to Hold. Target earned $1.54 in the third quarter, compared to $3.03 in the year-ago quarter. The current stock performance of Target shows a 52-week-high of $254.87 and a 52-week-low of $137.16. Moreover, at the end of the last trading period, the closing price was at $155.47.

    According to BMO Capital, the prior rating for Target Corp (NYSE:TGT) was changed from Outperform to Market Perform. In the third quarter, Target showed an EPS of $1.54, compared to $3.03 from the year-ago quarter. The stock has a 52-week-high of $254.87 and a 52-week-low of $137.16. At the end of the last trading period, Target closed at $155.47.

    According to B of A Securities, the prior rating for Surrozen Inc (NASDAQ:SRZN) was changed from Neutral to Underperform. Surrozen earned $0.38 in the third quarter, compared to $0.51 in the year-ago quarter.

    For REE Automotive Ltd (NASDAQ:REE), BTIG downgraded the previous rating of Buy to Neutral. In the third quarter, REE Automotive showed an EPS of $0.09, compared to $0.07 from the year-ago quarter. At the moment, the stock has a 52-week-high of $7.49 and a 52-week-low of $0.47. REE Automotive closed at $0.69 at the end of the last trading period.

    According to Evercore ISI Group, the prior rating for Principal Financial Group Inc (NASDAQ:PFG) was changed from In-Line to Underperform. For the third quarter, Principal Finl Gr had an EPS of $1.69, compared to year-ago quarter EPS of $1.69. At the moment, the stock has a 52-week-high of $96.17 and a 52-week-low of $61.05. Principal Finl Gr closed at $92.91 at the end of the last trading period.

    Morgan Stanley downgraded the previous rating for Principal Financial Group Inc (NASDAQ:PFG) from Equal-Weight to Underweight. Principal Finl Gr earned $1.69 in the third quarter, compared to $1.69 in the year-ago quarter. At the moment, the stock has a 52-week-high of $96.17 and a 52-week-low of $61.05. Principal Finl Gr closed at $92.91 at the end of the last trading period.

    Truist Securities downgraded the previous rating for Advance Auto Parts Inc (NYSE:AAP) from Buy to Hold. In the third quarter, Advance Auto Parts showed an EPS of $2.84, compared to $3.21 from the year-ago quarter. The stock has a 52-week-high of $244.55 and a 52-week-low of $150.35. At the end of the last trading period, Advance Auto Parts closed at $156.24.

    Credit Suisse downgraded the previous rating for Aveanna Healthcare Holdings Inc (NASDAQ:AVAH) from Outperform to Neutral. In the third quarter, Aveanna Healthcare Hldgs showed an EPS of $0.03, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $7.53 and a 52-week-low of $0.76. Aveanna Healthcare Hldgs closed at $0.80 at the end of the last trading period.

    For Brigham Minerals Inc (NYSE:MNRL), Piper Sandler downgraded the previous rating of Overweight to Neutral. For the third quarter, Brigham Minerals had an EPS of $0.69, compared to year-ago quarter EPS of $0.31. The stock has a 52-week-high of $36.49 and a 52-week-low of $20.53. At the end of the last trading period, Brigham Minerals closed at $36.12.

    For Membership Collective Group Inc (NYSE:MCG), JP Morgan downgraded the previous rating of Overweight to Neutral. Membership Collective earned $0.19 in the third quarter, compared to $0.72 in the year-ago quarter. The current stock performance of Membership Collective shows a 52-week-high of $13.06 and a 52-week-low of $3.14. Moreover, at the end of the last trading period, the closing price was at $3.86.

    According to RBC Capital, the prior rating for Two Harbors Investment Corp (NYSE:TWO) was changed from Outperform to Sector Perform. For the third quarter, Two Harbors Investment had an EPS of $0.64, compared to year-ago quarter EPS of $0.24. The stock has a 52-week-high of $24.00 and a 52-week-low of $12.12. At the end of the last trading period, Two Harbors Investment closed at $16.41.

    Credit Suisse downgraded the previous rating for Norwegian Cruise Line Holdings Ltd (NYSE:NCLH) from Outperform to Underperform. For the third quarter, Norwegian Cruise Line had an EPS of $0.64, compared to year-ago quarter EPS of $2.17. At the moment, the stock has a 52-week-high of $23.90 and a 52-week-low of $10.31. Norwegian Cruise Line closed at $17.59 at the end of the last trading period.

    See all analyst ratings downgrades.

    Initiations

    Northland Capital Markets initiated coverage on Franklin Covey Co (NYSE:FC) with an Outperform rating. The price target for Franklin Covey is set to $100.00. For the fourth quarter, Franklin Covey had an EPS of $0.39, compared to year-ago quarter EPS of $0.13. At the moment, the stock has a 52-week-high of $54.70 and a 52-week-low of $34.00. Franklin Covey closed at $49.49 at the end of the last trading period.

    With a Market Perform rating, Keefe, Bruyette & Woods initiated coverage on Root Inc (NASDAQ:ROOT). The price target seems to have been set at $9.00 for Root. In the third quarter, Root showed an EPS of $4.54, compared to $9.54 from the year-ago quarter. The current stock performance of Root shows a 52-week-high of $21.38 and a 52-week-low of $0.94. Moreover, at the end of the last trading period, the closing price was at $8.10.

    Keefe, Bruyette & Woods initiated coverage on Lemonade Inc (NYSE:LMND) with a Market Perform rating. The price target for Lemonade is set to $24.00. For the third quarter, Lemonade had an EPS of $1.37, compared to year-ago quarter EPS of $1.08. At the moment, the stock has a 52-week-high of $44.50 and a 52-week-low of $15.99. Lemonade closed at $21.57 at the end of the last trading period.

    With an Outperform rating, Keefe, Bruyette & Woods initiated coverage on Hippo Holdings Inc (NYSE:HIPO). The price target seems to have been set at $24.00 for Hippo Holdings. Hippo Holdings earned $3.24 in the third quarter, compared to $2.00 in the year-ago quarter. The current stock performance of Hippo Holdings shows a 52-week-high of $71.25 and a 52-week-low of $13.42. Moreover, at the end of the last trading period, the closing price was at $13.71.

    With an Overweight rating, Morgan Stanley initiated coverage on Ventyx Biosciences Inc (NASDAQ:VTYX). The price target seems to have been set at $45.00 for Ventyx Biosciences. In the third quarter, Ventyx Biosciences showed an EPS of $0.59, compared to $3.17 from the year-ago quarter. The stock has a 52-week-high of $41.29 and a 52-week-low of $9.50. At the end of the last trading period, Ventyx Biosciences closed at $25.43.

    With an Overweight rating, Cantor Fitzgerald initiated coverage on Theratechnologies Inc (NASDAQ:THTX). The price target seems to have been set at $9.00 for Theratechnologies. For the third quarter, Theratechnologies had an EPS of $0.08, compared to year-ago quarter EPS of $0.10. The stock has a 52-week-high of $3.26 and a 52-week-low of $1.74. At the end of the last trading period, Theratechnologies closed at $1.88.

    With a Buy rating, B. Riley Securities initiated coverage on Energy Recovery Inc (NASDAQ:ERII). The price target seems to have been set at $28.00 for Energy Recovery. Energy Recovery earned $0.12 in the third quarter, compared to $0.02 in the year-ago quarter. At the moment, the stock has a 52-week-high of $26.34 and a 52-week-low of $16.92. Energy Recovery closed at $20.93 at the end of the last trading period.

    With a Buy rating, Stifel initiated coverage on Dragonfly Energy Holdings Corp (NASDAQ:DFLI). The price target seems to have been set at $12.00 for Dragonfly Energy Hldgs. The stock has a 52-week-high of $17.68 and a 52-week-low of $6.75. At the end of the last trading period, Dragonfly Energy Hldgs closed at $7.97.

    With a Buy rating, BTIG initiated coverage on Vaxcyte Inc (NASDAQ:PCVX). The price target seems to have been set at $69.00 for Vaxcyte. For the third quarter, Vaxcyte had an EPS of $0.93, compared to year-ago quarter EPS of $0.51. The stock has a 52-week-high of $46.57 and a 52-week-low of $16.78. At the end of the last trading period, Vaxcyte closed at $43.35.

    Cantor Fitzgerald initiated coverage on KemPharm Inc (NASDAQ:KMPH) with an Overweight rating. The price target for KemPharm is set to $20.00. For the third quarter, KemPharm had an EPS of $0.19, compared to year-ago quarter EPS of $0.06. The stock has a 52-week-high of $9.43 and a 52-week-low of $4.00. At the end of the last trading period, KemPharm closed at $4.39.

    Canaccord Genuity initiated coverage on Traeger Inc (NYSE:COOK) with a Buy rating. The price target for Traeger is set to $6.00. In the third quarter, Traeger showed an EPS of $0.21, compared to $0.06 from the year-ago quarter. At the moment, the stock has a 52-week-high of $12.38 and a 52-week-low of $2.52. Traeger closed at $3.87 at the end of the last trading period.

    Canaccord Genuity initiated coverage on Solo Brands Inc (NYSE:DTC) with a Buy rating. The price target for Solo Brands is set to $7.00. For the third quarter, Solo Brands had an EPS of $0.15, compared to year-ago quarter EPS of $0.04. The stock has a 52-week-high of $17.45 and a 52-week-low of $3.50. At the end of the last trading period, Solo Brands closed at $4.67.

    Canaccord Genuity initiated coverage on YETI Holdings Inc (NYSE:YETI) with a Buy rating. The price target for YETI Holdings is set to $58.00. YETI Holdings earned $0.63 in the third quarter, compared to $0.64 in the year-ago quarter. The current stock performance of YETI Holdings shows a 52-week-high of $83.00 and a 52-week-low of $27.86. Moreover, at the end of the last trading period, the closing price was at $43.04.

    Canaccord Genuity initiated coverage on Olaplex Holdings Inc (NASDAQ:OLPX) with a Buy rating. The price target for Olaplex Hldgs is set to $8.00. For the third quarter, Olaplex Hldgs had an EPS of $0.11, compared to year-ago quarter EPS of $0.11. At the moment, the stock has a 52-week-high of $30.30 and a 52-week-low of $3.80. Olaplex Hldgs closed at $5.67 at the end of the last trading period.

    With a Buy rating, Canaccord Genuity initiated coverage on Prestige Consumer Healthcare Inc (NYSE:PBH). The price target seems to have been set at $71.00 for Prestige Consumer. In the second quarter, Prestige Consumer showed an EPS of $1.02, compared to $1.02 from the year-ago quarter. The current stock performance of Prestige Consumer shows a 52-week-high of $62.84 and a 52-week-low of $48.51. Moreover, at the end of the last trading period, the closing price was at $58.35.

    With a Buy rating, Canaccord Genuity initiated coverage on e.l.f. Beauty Inc (NYSE:ELF). The price target seems to have been set at $63.00 for e.l.f. Beauty. e.l.f. Beauty earned $0.36 in the second quarter, compared to $0.21 in the year-ago quarter. The current stock performance of e.l.f. Beauty shows a 52-week-high of $53.35 and a 52-week-low of $20.49. Moreover, at the end of the last trading period, the closing price was at $52.92.

    Canaccord Genuity initiated coverage on Helen Of Troy Ltd (NASDAQ:HELE) with a Buy rating. The price target for Helen Of Troy is set to $120.00. For the second quarter, Helen Of Troy had an EPS of $2.27, compared to year-ago quarter EPS of $2.65. The current stock performance of Helen Of Troy shows a 52-week-high of $249.08 and a 52-week-low of $82.94. Moreover, at the end of the last trading period, the closing price was at $99.41.

    With a Buy rating, Canaccord Genuity initiated coverage on Edgewell Personal Care Co (NYSE:EPC). The price target seems to have been set at $48.00 for Edgewell Personal Care. For the fourth quarter, Edgewell Personal Care had an EPS of $0.79, compared to year-ago quarter EPS of $1.01. The current stock performance of Edgewell Personal Care shows a 52-week-high of $51.86 and a 52-week-low of $32.00. Moreover, at the end of the last trading period, the closing price was at $39.93.

    Canaccord Genuity initiated coverage on Grove Collaborative Holdings Inc (NYSE:GROV) with a Buy rating. The price target for Grove Collaborative Hldgs is set to $2.00. At the moment, the stock has a 52-week-high of $12.50 and a 52-week-low of $1.01. Grove Collaborative Hldgs closed at $1.13 at the end of the last trading period.

    Canaccord Genuity initiated coverage on Thorne HealthTech Inc (NASDAQ:THRN) with a Buy rating. The price target for Thorne HealthTech is set to $5.50. Thorne HealthTech earned $0.12 in the third quarter, compared to $0.01 in the year-ago quarter. The current stock performance of Thorne HealthTech shows a 52-week-high of $7.38 and a 52-week-low of $3.41. Moreover, at the end of the last trading period, the closing price was at $4.15.

    With a Buy rating, Canaccord Genuity initiated coverage on The Middleby Corp (NASDAQ:MIDD). The price target seems to have been set at $171.00 for The Middleby. In the third quarter, The Middleby showed an EPS of $2.18, compared to $1.92 from the year-ago quarter. At the moment, the stock has a 52-week-high of $201.34 and a 52-week-low of $120.30. The Middleby closed at $139.84 at the end of the last trading period.

    Canaccord Genuity initiated coverage on Energizer Holdings Inc (NYSE:ENR) with a Hold rating. The price target for Energizer Holdings is set to $34.00. Energizer Holdings earned $0.82 in the fourth quarter, compared to $0.79 in the year-ago quarter. At the moment, the stock has a 52-week-high of $41.62 and a 52-week-low of $24.81. Energizer Holdings closed at $31.99 at the end of the last trading period.

    Canaccord Genuity initiated coverage on The Estee Lauder Companies Inc (NYSE:EL) with a Hold rating. The price target for Estee Lauder Cos is set to $228.00. In the first quarter, Estee Lauder Cos showed an EPS of $1.37, compared to $1.89 from the year-ago quarter. At the moment, the stock has a 52-week-high of $374.20 and a 52-week-low of $186.47. Estee Lauder Cos closed at $222.91 at the end of the last trading period.

    With an Outperform rating, National Bank Of Canada initiated coverage on i-80 Gold Corp (AMEX:IAUX). The price target seems to have been set at $4.25 for i-80 Gold. i-80 Gold earned $0.06 in the third quarter, compared to $0.04 in the year-ago quarter. The current stock performance of i-80 Gold shows a 52-week-high of $2.90 and a 52-week-low of $1.52. Moreover, at the end of the last trading period, the closing price was at $2.42.

    With an Outperform rating, RBC Capital initiated coverage on LSB Industries Inc (NYSE:LXU). The price target seems to have been set at $20.00 for LSB Industries. In the third quarter, LSB Industries showed an EPS of $0.27, compared to $0.07 from the year-ago quarter. The stock has a 52-week-high of $27.45 and a 52-week-low of $9.06. At the end of the last trading period, LSB Industries closed at $13.27.

    See all analyst ratings initiations.

    Get the next $AAP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAP
    $AGIO
    $ALE
    $ARDX

    CompanyDatePrice TargetRatingAnalyst
    Saia Inc.
    $SAIA
    2/11/2026$425.00Positive → Neutral
    Susquehanna
    Norwegian Cruise Line Holdings Ltd.
    $NCLH
    2/11/2026$23.00Overweight → Equal Weight
    Barclays
    Saia Inc.
    $SAIA
    2/10/2026$250.00Equal-Weight → Underweight
    Morgan Stanley
    Estee Lauder Companies Inc.
    $EL
    2/10/2026$106.00Buy → Hold
    HSBC Securities
    Norfolk Southern Corporation
    $NSC
    2/6/2026$342.00Buy → Neutral
    UBS
    Hub Group Inc.
    $HUBG
    2/6/2026$27.00Buy → Sell
    Stifel
    Hub Group Inc.
    $HUBG
    2/6/2026$29.00Outperform → Neutral
    Robert W. Baird
    Estee Lauder Companies Inc.
    $EL
    2/6/2026$120.00Neutral → Buy
    Citigroup
    More analyst ratings

    $AAP
    $AGIO
    $ALE
    $ARDX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated

    10/20/23 4:37:52 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:43:04 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZA™ issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZA™ (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:37:08 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAP
    $AGIO
    $ALE
    $ARDX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Tcg Crossover Gp Ii, Llc bought $202,534 worth of shares (9,357 units at $21.65) (SEC Form 4)

    4 - Surrozen, Inc./DE (0001824893) (Issuer)

    2/3/26 8:03:54 PM ET
    $SRZN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Large owner Column Group Iii Gp, Lp bought $641,597 worth of shares (32,507 units at $19.74) (SEC Form 4)

    4 - Surrozen, Inc./DE (0001824893) (Issuer)

    1/20/26 7:35:33 PM ET
    $SRZN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Kutzkey Tim bought $641,597 worth of shares (32,507 units at $19.74) (SEC Form 4)

    4 - Surrozen, Inc./DE (0001824893) (Issuer)

    1/20/26 7:31:54 PM ET
    $SRZN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAP
    $AGIO
    $ALE
    $ARDX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP Corporate Citizenship Thigpen Richard T covered exercise/tax liability with 237 shares, decreasing direct ownership by 0.93% to 25,275 units (SEC Form 4)

    4 - PUBLIC SERVICE ENTERPRISE GROUP INC (0000788784) (Issuer)

    2/12/26 7:18:07 PM ET
    $PEG
    Power Generation
    Utilities

    Chair, President and CEO Larossa Ralph A covered exercise/tax liability with 5,340 shares, decreasing direct ownership by 3% to 195,303 units (SEC Form 4)

    4 - PUBLIC SERVICE ENTERPRISE GROUP INC (0000788784) (Issuer)

    2/12/26 7:18:02 PM ET
    $PEG
    Power Generation
    Utilities

    SVP CAO & CHRO Rostiac Sheila J covered exercise/tax liability with 391 shares, decreasing direct ownership by 0.97% to 39,977 units (SEC Form 4)

    4 - PUBLIC SERVICE ENTERPRISE GROUP INC (0000788784) (Issuer)

    2/12/26 7:18:06 PM ET
    $PEG
    Power Generation
    Utilities

    $AAP
    $AGIO
    $ALE
    $ARDX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Saia downgraded by Susquehanna with a new price target

    Susquehanna downgraded Saia from Positive to Neutral and set a new price target of $425.00

    2/11/26 7:50:53 AM ET
    $SAIA
    Trucking Freight/Courier Services
    Industrials

    Norwegian Cruise Line downgraded by Barclays with a new price target

    Barclays downgraded Norwegian Cruise Line from Overweight to Equal Weight and set a new price target of $23.00

    2/11/26 7:50:17 AM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    Saia downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Saia from Equal-Weight to Underweight and set a new price target of $250.00

    2/10/26 2:29:18 PM ET
    $SAIA
    Trucking Freight/Courier Services
    Industrials

    $AAP
    $AGIO
    $ALE
    $ARDX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Root, Inc. to Participate in the 2026 Association of Insurance and Financial Analysts (AIFA) Conference

    COLUMBUS, Ohio, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Root, Inc. (NASDAQ:ROOT), a leading technology company powering insurance solutions and the parent company of Root Insurance, today announced its participation in the 2026 Association of Insurance and Financial Analysts (AIFA) Conference, taking place March 1-3, 2026, in Naples, Florida. While there will be no Company presentation, Root, Inc. will host one-on-one and group meetings with institutional investors. The investor material to be used in the meetings can be found on the home page of Root's Investor Relations website at ir.joinroot.com. The AIFA Conference is a premier gathering for leaders across the property & casualty insurance

    2/12/26 4:30:00 PM ET
    $ROOT
    Property-Casualty Insurers
    Finance

    Norwegian Cruise Line Holdings Appoints John W. Chidsey as President and Chief Executive Officer

    MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH), a leading global cruise company operating Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises, today announced that its Board of Directors has appointed John W. Chidsey, a director of NCLH, as President and Chief Executive Officer, effective immediately. Mr. Chidsey succeeds Harry Sommer, who is stepping down as President and Chief Executive Officer and as a Director of NCLH. Mr. Chidsey has a proven track record of leading large global consumer-facing companies through strategic and operational transformation, with experience across franchised operating models, as well as yield-dri

    2/12/26 4:15:00 PM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    Norwegian Cruise Line Holdings to Hold Conference Call on Fourth Quarter and Full Year 2025 Financial Results

    MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) (together with NCL Corporation Ltd., "Norwegian Cruise Line Holdings" or the "Company") announced today it will report fourth quarter and full year 2025 financial results on Monday, March 2, 2026 at 6:30 a.m. Eastern Time with a conference call and webcast to discuss results at 8:00 a.m. Eastern Time. The conference call will be webcast via the Company's Investor Relations website, https://www.nclhltd.com/investors. A replay of the webcast will be available here on the Company's website for 30 days following the call. About Norwegian Cruise Line Holdings Ltd. Norwegian Cruise Line Holdings Ltd. (NYS

    2/12/26 4:15:00 PM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    $AAP
    $AGIO
    $ALE
    $ARDX
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Workday Inc.

    SCHEDULE 13G/A - Workday, Inc. (0001327811) (Subject)

    2/12/26 9:58:50 PM ET
    $WDAY
    EDP Services
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Edgewell Personal Care Company

    SCHEDULE 13G/A - EDGEWELL PERSONAL CARE Co (0001096752) (Subject)

    2/12/26 5:17:21 PM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary

    Norwegian Cruise Line Holdings Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

    8-K - Norwegian Cruise Line Holdings Ltd. (0001513761) (Filer)

    2/12/26 4:20:30 PM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    $AAP
    $AGIO
    $ALE
    $ARDX
    Leadership Updates

    Live Leadership Updates

    View All

    Norwegian Cruise Line Holdings Appoints John W. Chidsey as President and Chief Executive Officer

    MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH), a leading global cruise company operating Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises, today announced that its Board of Directors has appointed John W. Chidsey, a director of NCLH, as President and Chief Executive Officer, effective immediately. Mr. Chidsey succeeds Harry Sommer, who is stepping down as President and Chief Executive Officer and as a Director of NCLH. Mr. Chidsey has a proven track record of leading large global consumer-facing companies through strategic and operational transformation, with experience across franchised operating models, as well as yield-dri

    2/12/26 4:15:00 PM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    Circana Appoints Highly Regarded Business Leaders to Board of Directors

    Chicago, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Circana LLC, a leading global provider of data, insights, and advisory services, today announced the appointment of three new members to its Board of Directors: Brian Cornell, Executive Chair of Target Corp.; Lauren Cooks Levitan, Co-Founder and Co-CEO of ROOT and Lead Independent Director at e.l.f. Beauty, Inc.; and Rohit Prasad, former Senior Vice President and Head Scientist of Artificial General Intelligence at Amazon.com, Inc. "These appointments strengthen the Board's ability to guide Circana's strategy and accelerate the value we deliver to our global clients," said Stuart Aitken, President and CEO of Circana. "We are focused on advancing

    2/11/26 8:00:00 AM ET
    $AMZN
    $TGT
    Catalog/Specialty Distribution
    Consumer Discretionary
    Department/Specialty Retail Stores

    Workday Announces CEO Transition as Co-Founder Aneel Bhusri Returns to Lead the Company's Next Chapter

    Carl Eschenbach Steps Down After Leading Company Through a Period of Global Expansion and Operational Scale Company Reaffirms Fiscal 2026 Fourth Quarter and Full-Year Outlook PLEASANTON, Calif., Feb. 9, 2026 /PRNewswire/ -- Workday, Inc. (NASDAQ:WDAY), the enterprise AI platform for managing people, money, and agents, today announced that co-founder and current executive chair Aneel Bhusri is returning as chief executive officer as the company enters its next chapter, focused on leading in the rapidly evolving AI era. Carl Eschenbach is stepping down as CEO and as a member of the board after leading Workday through a period defined by global growth, an expanded industry focus, and strengthen

    2/9/26 8:30:00 AM ET
    $WDAY
    EDP Services
    Technology

    $AAP
    $AGIO
    $ALE
    $ARDX
    Financials

    Live finance-specific insights

    View All

    Norwegian Cruise Line Holdings to Hold Conference Call on Fourth Quarter and Full Year 2025 Financial Results

    MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) (together with NCL Corporation Ltd., "Norwegian Cruise Line Holdings" or the "Company") announced today it will report fourth quarter and full year 2025 financial results on Monday, March 2, 2026 at 6:30 a.m. Eastern Time with a conference call and webcast to discuss results at 8:00 a.m. Eastern Time. The conference call will be webcast via the Company's Investor Relations website, https://www.nclhltd.com/investors. A replay of the webcast will be available here on the Company's website for 30 days following the call. About Norwegian Cruise Line Holdings Ltd. Norwegian Cruise Line Holdings Ltd. (NYS

    2/12/26 4:15:00 PM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    Franco-Nevada Announces $250 Million Royalty Financing with i-80 Gold

    (in U.S. dollars unless otherwise noted) TORONTO, Feb. 12, 2026 /PRNewswire/ - Franco-Nevada Corporation ("Franco-Nevada" or the "Company") (TSX:FNV)(NYSE:FNV) is pleased to announce that, through a wholly-owned U.S. subsidiary, it has entered into an agreement to acquire a $250 million net smelter return royalty (the "Royalty") from i-80 Gold Corp. ("i-80 Gold") to support its recapitalization plan and strategy of creating a Nevada-focused mid-tier gold producer. The Royalty rate will initially be 1.5%, increasing to 3.0% beginning in 2031, and will apply to all of i-80 Gold's material properties including their six projects in various stages of development. These projects cover more than 2

    2/12/26 7:22:00 AM ET
    $FNV
    $IAUX
    Precious Metals
    Basic Materials

    Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

    PYRUKYND® (mitapivat) worldwide net revenues of $20.0 million in fourth quarter and $54.0 million for full yearAQVESME™ (mitapivat) for thalassemia now available in U.S. following FDA approvalCompany will have pre-sNDA meeting with FDA for mitapivat in sickle cell disease in first quarter of 2026Phase 2 tebapivat trial in sickle cell disease fully enrolled; topline results expected in second half of 2026$1.2 billion dollars in cash, cash equivalents, and marketable securities as of December 31, 2025 CAMBRIDGE, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patie

    2/12/26 6:30:00 AM ET
    $AGIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAP
    $AGIO
    $ALE
    $ARDX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Estee Lauder Companies Inc.

    SC 13D/A - ESTEE LAUDER COMPANIES INC (0001001250) (Subject)

    12/10/24 6:06:03 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Estee Lauder Companies Inc.

    SC 13D/A - ESTEE LAUDER COMPANIES INC (0001001250) (Subject)

    12/9/24 5:30:41 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Estee Lauder Companies Inc.

    SC 13D/A - ESTEE LAUDER COMPANIES INC (0001001250) (Subject)

    12/9/24 5:30:28 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary